Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2004
09/21/2004US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders
09/21/2004US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells
09/21/2004US6793919 Methods for treating rheumatoid arthritis using IL-17 antagonists
09/21/2004CA2256718C Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
09/16/2004WO2004078758A1 Novel fused heterocycles and uses thereof
09/16/2004WO2004078751A1 Benzofuran derivative
09/16/2004WO2004078723A1 Novel compound having 4-pyridylalkylthio group as substituent
09/16/2004WO2004078719A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
09/16/2004WO2004078261A1 Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders
09/16/2004WO2004078217A1 Bone calcification promoter
09/16/2004WO2004078169A1 Use of ep2 selective receptor agonists in medical treatment
09/16/2004WO2004078167A1 Use of non-immunosuppressive pipecolic acid derivatives for inducing chondrogenic differentiation
09/16/2004WO2004067027A3 Osteogenic composition
09/16/2004WO2003105776A3 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
09/16/2004WO2003104253A3 9-alpha-substituted estratrienes as selectively active estrogen
09/16/2004WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins
09/16/2004WO2003052048A3 Nucleic acid-associated proteins
09/16/2004WO2003045318A3 Manipulation of cytokine levels using cd83 gene products
09/16/2004WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto
09/16/2004WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies
09/16/2004US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/16/2004US20040181066 Tyrosine kinase inhibitors
09/16/2004US20040181062 Benzimidazole cyclooxygenase-2 inhibitor
09/16/2004US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
09/16/2004US20040181047 33 human secreted proteins
09/16/2004US20040180963 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
09/16/2004US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system
09/16/2004US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate
09/16/2004US20040180914 5-Cyano-2-aminopyrimidine derivatives
09/16/2004US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable
09/16/2004US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
09/16/2004US20040180900 Therapeutic composition for repairing chondropathy
09/16/2004US20040180899 tyrosine kinase inhibitors
09/16/2004US20040180894 Benzamide inhibitors of the P2X7 receptor
09/16/2004US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
09/16/2004US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists
09/16/2004US20040180881 Oxazolyl-pyrazole derivatives as kinase inhibitors
09/16/2004US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
09/16/2004US20040180862 Combination of farnesyl diphosphate synthase inhibiting bisphosphonate and squalene synthase inhibitor; counteracting adverse gastrointestinal effects
09/16/2004US20040180856 Aqueous solution including partially methylated cyclodextrin
09/16/2004US20040180836 Blocking peptide for inflammatory cell secretion
09/16/2004US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
09/16/2004US20040180831 Efficiently lower serum calcium levels, bioavailability; chymotrypsin and/or trypsin degradation resistance; bone disorders
09/16/2004US20040180820 Spontaneous resorption of herniated disc; inducing vascular tubule formation using angiogenesis inducing substance
09/16/2004US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome)
09/16/2004CA2518193A1 Use of ep2 selective receptor agonists in medical treatment
09/16/2004CA2518100A1 Use of non-immunosuppressive pipecolic acid derivatives for inducing chondrogenic differentiation
09/16/2004CA2512280A1 Benzofuran derivative
09/15/2004EP1457493A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
09/15/2004EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity
09/15/2004EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor
09/15/2004EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
09/15/2004EP1456357A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
09/15/2004EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist
09/15/2004EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof
09/15/2004EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme
09/15/2004EP1456205A1 Imidazoquinoline derivatives
09/15/2004EP1456201A1 Benzhydryl derivatives
09/15/2004EP1456200A1 Lactams as tachykinin antagonists
09/15/2004EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
09/15/2004EP1456192A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds
09/15/2004EP1456179A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
09/15/2004EP1456160A2 Vitamin d analogues
09/15/2004EP1455841A2 Osteopontin-related compositions and methods
09/15/2004EP1455835A2 Method of modulating release of saccharides and uses thereof
09/15/2004EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof
09/15/2004EP1455796A1 Method for the treatment of bone disorders
09/15/2004EP1455791A1 Method for administering birb 796 bs
09/15/2004EP1455790A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
09/15/2004EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them
09/15/2004EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity
09/15/2004EP1455759A2 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
09/15/2004EP1455601A1 Composition for promotion of bone growth and maintenance of bone health
09/15/2004EP1455600A1 Food or pet food composition containing plant extract for bone health
09/15/2004EP1363902B1 Chemical compounds
09/15/2004EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
09/15/2004EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
09/15/2004EP0938326B1 Synthetic phosphopeptides for treating bone diseases
09/15/2004EP0889726B1 Novel cycloalkyl substituted imidazoles
09/15/2004CN1529704A 3-(4-amidopyrrol-2-2ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
09/15/2004CN1529701A Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof
09/15/2004CN1529699A Novel sulfonic acid derivatives
09/15/2004CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays
09/15/2004CN1529609A Herbal drug composition for cartilage protection
09/15/2004CN1529604A Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis
09/15/2004CN1529599A Acylic piperazine and piperidine derivatives which are used for treating neuronal damage
09/15/2004CN1529598A Method of treating demyelinating diseases or conditions
09/15/2004CN1529593A 2-pyrrolidone derivatives as prostanoid agonists
09/15/2004CN1529590A Compositions and methods to treat neovascularization and disease associated with thereof
09/15/2004CN1528876A Nototerygium root-eucommia wine and production method thereof
09/15/2004CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate
09/15/2004CN1528436A Chinese medicine preparation using rhizoma gastrodiae and eucommia as main material and preparing method thereof
09/15/2004CN1528432A Method for preparing medicine for treating rheumatoid arthritis
09/15/2004CN1528431A Bonesetting powder
09/15/2004CN1528415A Capsule for treating cervical spondylosis and hyperplastic arthritis and preparing process thereof
09/15/2004CN1528404A Medicine for treating numbness and preparing method thereof
09/15/2004CN1528386A Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof
09/15/2004CN1528375A Chinese medicine for treating protrasion of the lumber intervertebral disci
09/15/2004CN1528366A Semen strychni-lumbricus ointment for relieving pain
09/15/2004CN1528355A Chinese medicine comp osition for treating spondylodynia